Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

TB Notes Newsletter

(PDF - 7M)

No. 2, 2011

NEW CDC PUBLICATIONS

Adekambi T, Butler RW, Hanrahan F, Delcher AL, Drancourt M and Shinnick TM. Core gene set as the basis of multilocus sequence analysis of the subclass Actinobacteridae. PLoS One 2011 Mar 31;6(3):e14792. Epub date April 13, 2011.

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E,  Tahirli R, Gler MT, Blakemore R, Worodria W, Gray C, Huang L, Caceres T, Mehdiyev R, Raymond L, Whitelaw A, Sagadevan K, Alexander H, Albert H, Cobelens, Cox FH, Alland D and Perkins MD. Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 2011; 377(9776): 1495-1505.

Cain KP and Varma JK. You have to find TB to treat TB. [Editorial.] Int J Tuberc Lung Dis 2011; 15(7): 854.

Gust DA, Mosimaneotsile B, Mathebula U, Chingapane B, Gaul Z, Pals SL and Samandari T. Risk factors for non-adherence and loss to follow-up in a three-year clinical trial in Botswana. Plos One 2011; 6 (4).

Holtz TH, Kabera G, Mthiyane T, Zingoni T, Nadesan S, Ross D, Allen J, Chideya S, Sunpath H, Rustomjee R.  Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. Lancet Infect Dis 2011; 11: 533-40.

LoBue P. People aged above 65 treated for latent tuberculosis are at increased risk of admission for a hepatic event compared with untreated controls. Evid Based Med 2011 June 6. Epub date June 8, 2011.

Lowenthal P, Westenhouse J, Moore M, Posey DL, Watt JP, Flood J. Reduced importation of tuberculosis after the implementation of an enhanced pre-immigration screening protocol. Int J Tuberc Lung Dis 2011; 15(6):761–766.

Mac Kenzie WR, Heilig CM, Bozeman L, Johnson JL, Muzanye G, Dunbar D, Jost Jr, KC, Diem L, Metchock B, Eisenach K, Dorman  S and Goldberg S. Geographic differences in time to culture conversion in liquid media: Tuberculosis trials Consortium Study 28. Culture conversion is delayed in Africa. Plos One 2011; 6 (4).

Marks SM. Diabetes and tuberculosis, US National Health Interview Survey, 2000–2005. [Short communication.] Int J Tuberc Lung Dis 2011; 15(7):982–984.

Pratt RH, Winston CA, Kammerer JS and Armstrong LR. Tuberculosis in older adults in the United States, 1993-2008. Journal of the American Geriatrics Society 2011; 59 (5): 851-857.

Samandari T, Agizew TB, Nyirenda S, Tedla Z, Sibanda T, Shang N, Mosimaneotsile B, O. I. Motsamai, Bozeman L, Davis MK, Talbot EA, Moeti TL, Moffat H, Kilmarx PH, Castro KG and Wells CD. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011; 377 (9777): 1588-98.

Samandari T, Bishai D, Luteijn M, Mosimaneotsile B, Motsamai O, Postma  M and Hubben G. Costs and consequences of additional chest X-ray in a tuberculosis prevention program in Botswana. Am J Respir Crit Care Med 2011; 183 (8): 1103-11.

Sanchez F, Colomes JLL , Villarino E and Grosset J. New drugs for tuberculosis treatment. Enfermedades Infecciosas Y Microbiologia Clinica 2011; 29: 47-56.

Spencer JS, Kim HJ, Wheat WH, Chatterjee D, Balagon MV, Cellona RV, Tan EV, Gelber R, Saunderson P, Duthie MS, Reece ST, Burman W, Belknap R, Mac Kenzie WR, Geluk A, Oskam L, Dockrell HM, and Brennan PJ on behalf of the IDEAL Consortium. Analysis of antibody responses to Mycobacterium leprae phenolic glycolipid I, lipoarabinomannan, and recombinant proteins to define disease subtype-specific antigenic profiles in leprosy. Clinical and Vaccine Immunology 2011; 18 (2): 260-7.

Yasinskaya Y, Plikaytis B, Sizemore C, Sacks L. Advancing the development of diagnostic tests and biomarkers for tuberculosis. [Notes from the field.] Int J Tuberc Lung Dis 2011; 15(7): 985–987.

 

Contact Us:
  • Centers for Disease Control and Prevention
    Division of Tuberculosis Elimination (DTBE)
    1600 Clifton Rd., NE
    MS E10
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • New Hours of Operation
    8am-8pm ET/Monday-Friday
    Closed Holidays
  • cdcinfo@cdc.gov
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - cdcinfo@cdc.gov
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #